Loading clinical trials...

COMPLETEDPhase 4NCT05742841

EMERALD (Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders)

The EMERALD intervention involves 1) ordering an Emergency Department (ED) lipid panel, 2) calculating 10-year Atherosclerotic cardiovascular disease (ASCVD) risk using the Pooled Cohort Equations, 3)...

Lead sponsor: Wake Forest University Health Sciences•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITING

Familial Hypercholesterolemia Canada / Hypercholesterolemie Familiale Canada

NCT02009345 · Familial Hypercholesterolemia, Lipid Disorder

RECRUITINGNA

Short-term Fat Overfeeding on the Effects of Liver Metabolism

NCT05962190 · Liver Fat, Cardiac Function, and more

COMPLETEDNA

Effect of Plasma Ceramides on Peripheral Vascular Function

NCT05107869 · Peripheral Vascular Disease, Lipid Disorder, and more

COMPLETEDPhase 3

Vitamin D & Levothyroxine Combination Versus Levothyroxine on Lipid Profile in Hypothyroidism

NCT06276205 · Hypothyroidism Primary, Lipid Disorder, and more

COMPLETEDNA

Evaluation of the Consumption of Lupins in Brine on Metabolic Markers in Healthy Individuals

NCT06595082 · Lipid Disorder, Systemic Inflammatory Response

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 21, 2024Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE4

Enrollment22

Start dateMar 2023

Last updatedMay 21, 2024

Condition

Lipid Disorder

Locations shown

Wake Forest University Health Sciences

Winston-Salem, North Carolina

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 21, 2024Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions